Advanced therapy medicinal products
33 results
Applied filters
Medications for treating CRS and ICANS
2 October 2026Guidance on which medications to use when treating CRS and ICANS.
Diagnosis and management of ICANS
2 October 2026Guidance on the management of immune effector cell-associated neurotoxicity syndrome (ICANS) in adults receiving licensed CAR-T cell products.
Diagnosis and management of cytokine release syndrome (CRS)
2 October 2026Guidance on the management of CRS in adult patients receiving licensed CAR-T cell products.
Understanding acute CAR-T cell therapy toxicities in adults
2 October 2026Guidance on the management of acute side effects in adults receiving licensed CAR-T cell therapy products.
Advanced therapy medicinal products
All our resources and guidance to support the use of advanced therapy medicinal products (ATMPs) in the healthcare system.
Introduction to advanced therapy medicinal products (ATMPs)
25 February 2026ATMPs are biological medicines that use cells, genes or tissues to treat complex conditions including cancers, rare diseases and genetic disorders.
In-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo genetically modified organism (GMO) gene therapy.
Ex-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo genetically modified organism (GMO) gene therapy.
Tissue engineered products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing tissue engineered products.
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.